More than $300,000 worth of drugs and supplements from St. Louis-based General Therapeutics were seized by the FDA and the Marshals Service in response to a forfeiture complaint accusing the company of failing to correct violations of sanitary standards. The FDA in 1999 found General Therapeutics to be manufacturing drugs and dietary supplements under unsanitary conditions and threatened to seize its products if it failed to act on the violations.

Related Summaries